Nuvation Bio Inc.NUVBNYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +236.79% | +1704.68% | +633.06% |
| Gross Profit Growth | +0.00% | +0.00% | +2464.77% | +0.00% | +2672.04% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +53.92% | +54.58% | +39.23% | +25.16% | +2.20% |
| Weighted Average Shares Diluted Growth | +53.92% | +54.58% | +39.23% | +25.16% | +2.20% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +340.09% | +27.53% | +66.43% | +225.73% | +18.84% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -13.01% | -19.68% | +8.81% | +5.25% | +10.02% |
| Book Value per Share Growth | -50.20% | -54.32% | +4.14% | -48.21% | -35.50% |
| Debt Growth | +122.49% | +223.13% | +293.43% | +414.19% | +13.82% |
| R&D Expense Growth | +90.86% | +91.57% | -93.98% | +4.02% | +17.06% |
| SG&A Expenses Growth | +376.97% | +381.08% | +138.20% | +90.78% | +54.28% |